Precipio Receives CE-IVD Mark for Hematologic Cancer Panels
The company said it can now market its HemeScreen MPN, AML, Anemia/MDS, and CLL panels in the European Union and the UK.
Source: precisiononcologynews.com
Stay updated with breaking news from High Resolution Melt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company said it can now market its HemeScreen MPN, AML, Anemia/MDS, and CLL panels in the European Union and the UK.